Selling by month
Oct 2025 to Oct 2026. Each sale is counted once: under a disclosed plan, else to cover taxes, else no plan disclosed.
Disclosed planOne dollar scale for every month; the tallest bar is labeled
Pattern
What the filings show, past 12 months. Nothing here rates or predicts.
- Sold in 2 of the 13 calendar months from Oct 2025 to Oct 2026: Nov 2025 and Dec 2025.
- Largest single sale: $4.4M (110,000 shares) of Royalty Pharma plc on Dec 3, 2025. Filing
- Last sale before this period: Jun 6, 2023.
Roles from filings
Every company we track where this person has filed, newest filing first.
| Company | Title | First filing | Latest filing |
|---|---|---|---|
| Royalty Pharma plc (RPRX) | EVP, Investments & CLO | Jun 15, 2020 | Dec 19, 2025 |
Recent filings
The last 5 days with transactions, newest first, one line per trade date. Each number links to an SEC filing.
- Dec 18, 2025, Royalty Pharma plc: sold 30,654 shares for $1.2M, under a disclosed plan (some held indirectly). 1 filing: 1
- Dec 17, 2025, Royalty Pharma plc: sold 79,346 shares for $3.1M, under a disclosed plan (some held indirectly). 1 filing: 1
- Dec 3, 2025, Royalty Pharma plc: sold 110,000 shares for $4.4M, under a disclosed plan (some held indirectly). 1 filing: 1
- Nov 19, 2025, Royalty Pharma plc: sold 135,426 shares for $5.2M, under a disclosed plan (some held indirectly). 1 filing: 1
- Nov 5, 2025, Royalty Pharma plc: 6,168 shares awarded (some held indirectly). 1 filing: 1
This page shows only what this person reported on SEC ownership filings. See the methodology. Spotted something wrong? Report an error.